O
APTX

OrbiMed’s Aptinyx Inc. Common Stock APTX Stock Holding History

OrbiMed’s Portfolio APTX Stock Details APTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-538,500
Closed -$300 – 153
2022
Q2 		$300 Hold
538,500
– – 0.01% 143
2022
Q1 		$1.22M Sell
538,500
-211,000
-28% -$632K 0.02% 136
2021
Q4 		$2M Buy
749,500
+596,215
+389% +$1.43M 0.03% 151
2021
Q3 		$359K Buy
+153,285
New +$391K ﹤0.01% 170
2020
Q2 		– Sell
-1,162,108
Closed -$2.51M – 165
2020
Q1 		$2.51M Buy
1,162,108
+1,019,108
+713% +$3.33M 0.04% 124
2019
Q4 		$489K Buy
+143,000
New +$492K 0.01% 134

Other funds holding APTX

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return